Trisha Shetty (Editor)

BMS 906024

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
PubChem CID  66550890
ChemSpider  28536138
3D model (Jmol)  Interactive image
PubChem SID  152143555
Formula  C26H26F6N4O3
Molar mass  556.5 g/mol
BMS-906024 httpsuploadwikimediaorgwikipediacommonsthu

New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, and colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and it currently being studied in clinical trials.


BMS-906024 Wikipedia